Allogeneic versus autologous blood transfusion and survival after radical prostatectomy

Transfusion

Volumn 54, Issue 9, 2014, Pages 2168-2174

  Chalfin, Heather J ^a   Frank, Steven M ^a   Feng, Zhaoyong ^a   Trock, Bruce J ^a   Drake, Charles G ^a   Partin, Alan W ^a   Humphreys, Elizabeth ^a   Ness, Paul M ^a   Jeong, Byong C ^a   Lee, Seung B ^a   Han, Misop ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BLOOD TRANSFUSION; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BODY MASS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; AGED; ALLOTRANSPLANTATION; MIDDLE AGED; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS;

ADULT; AGED; BLOOD TRANSFUSION, AUTOLOGOUS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84908154177     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12611     Document Type: Article

References (32)

1. Carson JL, Grossman BJ, Kleinman S, et al. Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49-58.
2. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012;(4): CD002042.
3. Goodnough LT, Bach RG. Anemia, transfusion, and mortality. N Engl J Med 2001;345:1272-4.
4. Herbert PC, Wells G. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-17. Erratum in: N Engl J Med: 1;340(13):1056, 1999.
5. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21:327-48.
6. Wu WC, Smith TS, Henderson WG, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 2010; 252:11-7.
7. Dresner SM, Lamb PJ, Shenfine J, et al. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000;26:492-7.
8. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
9. Shiba H, Ishida Y, Wakiyama S, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 2009;13:1636-42.
10. Eickhoff JH, Andersen J, Laybourn C. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. The Danish Breast Cancer Cooperative Group. Br J Surg 1991;78:1358-61.
11. Keller SM, Groshen S, Martini N, et al. Blood transfusion and lung cancer recurrence. Cancer 1988;62: 606-10.
12. Morgan TM, Barocas DA, Chang SS, et al. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 2013;31:871-7.
13. Guzzo TJ, Dluzniewski P, Orosco R, et al. Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology 2010;76:553-7.
14. Ford BS, Sharma S, Rezaishiraz H. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008;26:364-7.
15. Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006;67:137-41.
16. Ness PM, Walsh PC, Zahurak M, et al. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992;32:31-6.
17. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988;156:374-80.
18. McClinton S, Moffat LE, Scott S, et al. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990;77:140-2.
19. King KE, Shirey RS. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004;44:25-9.
20. Chalmers KA, Knuiman MW, Divitini ML, et al. Long-term mortality risks associated with mild anaemia in older persons: the Busselton Health Study. Age Ageing 2012;41: 759-64.
21. Carless P, Moxey A, O'Connell D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004;14:123-44.
22. Park JO, Gonen M, D'Angelica MI, et al. Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome. J Gastrointest Surg 2007;11: 1286-93.
23. Raval JS, Nelson JB, Woldemichael E, et al. Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012;52:2590-3.
24. Henry DA, Moxey AJ, Carless PA, et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2001;(2):CD001884. Review. Update in: Cochrane Database Syst Rev CD001884, 2004.
25. Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009;(1):CD007148.
26. Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009;302:1557-64.
27. Malone DL, Dunne J, Tracy JK, et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003;54:898-905.
28. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-4. 2997.
29. Claridge JA, Sawyer RG, Schulman AM, et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 2002;68:566-72.
30. Bilgin YM, van de Watering LM, Eijsman L, et al. Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis. Transfus Med 2007;17:304-11.
31. Hughes MG, Evans HL, Lightfoot L, et al. Does prior transfusion worsen outcomes from infection in surgical patients? Surg Infect (Larchmt) 2003;4:335-43.
32. Bloch EM, Jackman RP, Lee TH. Transfusion-associated microchimerism: the hybrid within. Transfus Med Rev 2013;27:10-20.